That is what I hope for, I have not been guided by anybody on this. I base it on the fact that this is just an interim on a small sample size (270 patients).
It could well be 2 weeks, 3weeks a month?
I know that Starpharma announced they finished two of their P3 trials, and advised the full analysis and compilation would take 10-12 weeks. However their trial had a much larger dataset, and it is final - so there will be QC and auditing requiring. Ours is just an interim, with a recommendation given.
That is what I hope for, I have not been guided by anybody on...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |